Julie Harb · Policy Advisor, Prime Minister's Office (PMO)
Alyth Roos · Special Assistant Policy, Prime Minister's Office (PMO)
To advocate for ongoing funding through for Indigenous groups the Emergency Treatment Fund.Read more
To discuss proposal to leverage medical countermeasure (biodefence) manufacturing in Canada as portion of NATO GDP commitment. Explore partnership and investment opportunities to support the growth of the life sciences sector in Manitoba. To request funding from ISED via LSF to grow the Emergent facility in Winnipeg.
To discuss proposal to leverage medical countermeasure (biodefence) manufacturing in Canada as portion of NATO GDP commitment. Explore partnership and investment opportunities to support the growth of the life sciences sector in Manitoba. To request funding from ISED via LSF to grow the Emergent facility in Winnipeg.Read more
To increase access to publicly funded nasal naloxone.
To advocate for ongoing funding through for Indigenous groups the Emergency Treatment Fund.
Quinn Ferris · Regional Advisor, National Defence, National Defence (DND)
To discuss proposal to leverage medical countermeasure (biodefence) manufacturing in Canada as portion of NATO GDP commitment. Explore partnership and investment opportunities to support the growth of the life sciences sector in Manitoba. To request funding from ISED via LSF to grow the Emergent facility in Winnipeg.Read more
Jocelyn Milburn · Director, Health Emergency Readiness Canada (HERC), Innovation, Science and Economic Development Canada (ISED)
To discuss proposal to leverage medical countermeasure (biodefence) manufacturing in Canada as portion of NATO GDP commitment. Explore partnership and investment opportunities to support the growth of the life sciences sector in Manitoba.Read more
Timothy Smith · Deputy Program Manager, National Defence (DND)
Wendy Hepburn · Deputy Director, National Defence (DND)
To discuss proposal to leverage medical countermeasure (biodefence) manufacturing in Canada as portion of NATO GDP commitment. Explore partnership and investment opportunities to support the growth of the life sciences sector in Manitoba.Read more
Jocelyn Milburn · Director, HERC, Innovation, Science and Economic Development Canada (ISED)
Alison McConnell · Deputy Director, Innovation, Science and Economic Development Canada (ISED)
To discuss proposal to leverage medical countermeasure (biodefence) manufacturing in Canada as portion of NATO GDP commitment. Explore partnership and investment opportunities to support the growth of the life sciences sector in Manitoba.Read more
Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
To discuss proposal to leverage medical countermeasure (biodefence) manufacturing in Canada as portion of NATO GDP commitment. Explore partnership and investment opportunities to support the growth of the life sciences sector in Manitoba.Read more
Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
Wendy Hadwen · Assistant Deputy Minister, National Defence (DND)
Wendy Hepburn · Deputy Director, National Defence (DND)
To discuss proposal to leverage medical countermeasure (biodefence) manufacturing in Canada as portion of NATO GDP commitment. Explore partnership and investment opportunities to support the growth of the life sciences sector in Manitoba.Read more
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026.
Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month.
Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means.
Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence.
PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.